Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Understand the key factors for determining when to sell stocks and buy bonds to optimize your investment strategy.
28,656 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Cisco surprised investors with strong quarterly results and higher guidance, boosting its stock and signaling robust ...
Quantum stocks have been front and center as grants and hype push prices higher. This guide explains why infleqtion s...
Imagine the next 10 years of your portfolio. This piece explains why Costco's shine may not translate into a top inve...
CrowdStrike is set to report Q4 results after the close, with analysts predicting a beat on non-GAAP earnings and rev...
A veteran portfolio manager recounts selling a 19-bagger too early and explains how that misstep reshaped his long-te...
Bitcoin slumped sharply while major altcoins fell, erasing about $150 billion from crypto markets and stirring a fres...
A teacher faces a tempting lump-sum move to boost pension benefits. Experts warn that a $50,000 IRA decision may trap...
The SEC has proposed scrapping Rule 611 and Rule 610(e), a step that could transform tokenized US stocks trading in D...
Best Buy preserves a 22-year streak of dividend hikes with a 6.1% yield, yet cash flow trends and external headwinds ...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
A fresh SEC filing shows AREX Capital Management opening a new stake in CALY with 453,000 shares worth about $5.29 mi...